arrow
Back
I

Ingrid Spadinger

bc cancer

25H-index
131Paper Count
2.0KCitation Count
Published Papers 35
Publication Date
Trends in brachytherapy utilization in Canada from 2011 to 2020
err2026-04-30
err0
errOAAI
errMirta Dumancic; Yujing Zou; Harry Glickman; Sara Ghassimi Kouraneh; Piotr Pater; Andrew Alexander; Jorge E. Alpuche Aviles; Amanda Cherpak; Kristin Marchant; Geetha Menon; Daniel Morton; Tim Olding; Moti Paudel; Alexandra Rink; Ingrid Spadinger; Shirin A. Enger
errShare
errSave
Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy
err2022-01-01
err2
errOAAI
errUrban, Ryan; Wong, Justin; Lim, Peter; Zhang, Susan; Spadinger, Ingrid; Olson, Robert; Bachand, Francois; Ho, Clement; Tinker, Anna, V; Gondara, Lovedeep; Hamilton, Sarah Nicole
errShare
errSave
Automatic detection of brachytherapy seeds in 3D ultrasound images using a convolutional neural network
err2020-02-05
err13
PREAI
errGolshan, Maryam; Karimi, Davood; Mahdavi, Sara; Lobo, Julio; Peacock, Michael; Salcudean, Septimiu E.; Spadinger, Ingrid
errShare
errSave
Accurate and robust deep learning-based segmentation of the prostate clinical target volume in ultrasound images
err2019-10-01
err78
PREAI
errKarimi, Davood; Zeng, Qi; Mathur, Prateek; Avinash, Apeksha; Mandavi, Sara; Spadinger, Ingrid; Abolmaesumi, Purang; Salcudean, Septimiu E.
errShare
errSave
Propagation of registration uncertainty during multi-fraction cervical cancer brachytherapy
err2017-10-04
err6
PREAI
errAmir-Khalili, A.; Hamarneh, G.; Zakariaee, R.; Spadinger, I.; Abugharbieh, R.
errShare
errSave
Bladder accumulated dose in image-guided high-dose-rate brachytherapy for locally advanced cervical cancer and its relation to urinary toxicity
err2016-11-15
err9
PREAI
errZakariaee, Roja; Hamarneh, Ghassan; Brown, Colin J.; Gaudet, Marc; Aquino-Parsons, Christina; Spadinger, Ingrid
errShare
errSave
Learning-Based Multi-Label Segmentation of Transrectal Ultrasound Images for Prostate Brachytherapy
err2016-03-01
err28
PREAI
errNouranian, Saman; Ramezani, Mahdi; Spadinger, Ingrid; Morris, William J.; Salcudean, Septimu E.; Abolmaesumi, Purang
errShare
errSave
Validation of non-rigid point-set registration methods using a porcine bladder pelvic phantom
err2016-01-07
err6
PREAI
errZakariaee, Roja; Hamarneh, Ghassan; Brown, Colin J.; Spadinger, Ingrid
errShare
errSave
Infrastructure and Process for Model-Based Dose Calculation Software Commissioning in Brachytherapy
err2015-06-29
err0
PREAI
errSloboda, R.; Ballester, F.; Tedgren, A. Carlsson; Culberson, W.; Esthappans, J.; Haworth, A.; Lowenstein, J.; Ma, Y.; Mourtada, F.; Papagiannis, P.; Pike, T.; Rivard, M.; Siebert, F.; Smite, R.; Spadinger, I.; Taylor, P.; Verhaegen, F.; Vijande, J.; Beaulieu, L.
errShare
errSave
A Multi-Atlas-Based Segmentation Framework for Prostate Brachytherapy
err2015-04-01
err22
PREAI
errNouranian, Saman; Mahdavi, S. Sara; Spadinger, Ingrid; Morris, William J.; Salcudean, Septimu E.; Abolmaesumi, Purang
errShare
errSave
Late Urinary Side Effects 10 Years After Low-Dose-Rate Prostate Brachytherapy: Population-Based Results From a Multiphysician Practice Treating With a Standardized Protocol and Uniform Dosimetric Goals
err2014-11-01
err47
PREAI
errKeyes, Mira; Miller, Stacy; Pickles, Tom; Halperin, Ross; Kwan, Winkle; Lapointe, Vincent; McKenzie, Michael; Spadinger, Ingrid; Pai, Howard; Chan, Elisa K.; Morris, W. James
errShare
errSave
Prostate-Specific Antigen at 4 to 5 Years After Low-Dose-Rate Prostate Brachytherapy Is a Strong Predictor of Disease-Free Survival
err2014-01-01
err54
PREAI
errLo, Andrea C.; Morris, W. James; Lapointe, Vincent; Hamm, Jeremy; Keyes, Mira; Pickles, Tom; McKenzie, Michael; Spadinger, Ingrid
errShare
errSave
Prognostic Utility of the Prostate Specific Antigen (PSA) Value 4-5 Years After 125I Brachytherapy
err2013-10-01
err0
errOAAI
errLo, A.; Morris, W.; La Pointe, V.; Hamm, J.; Pickles, T.; Keyes, M.; McKenzie, M.; Spadinger, I.
errShare
errSave
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer
errCANCER
IF5.1
err2012-12-26
err96
PREAI
errMorris, W. James; Keyes, Mira; Spadinger, Ingrid; Kwan, Winkle; Liu, Mitchell; McKenzie, Michael; Pai, Howard; Pickles, Tom; Tyldesley, Scott
errShare
errSave
Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: A population-based cohort study
err2012-05-01
err20
PREAI
errHerbert, Christopher; Morris, W. James; Keyes, Mira; Hamm, Jeremy; Lapointe, Vincent; McKenzie, Michael; Pickles, Thomas; Spadinger, Ingrid
errShare
errSave
Prostate brachytherapy postimplant dosimetry: Seed orientation and the impact of dosimetric anisotropy in stranded implants
err2012-01-12
err9
PREAI
errChng, Nicholas; Spadinger, Ingrid; Rasoda, Rosey; Morris, W. James; Salcudean, Septimiu
errShare
errSave
Low Dose Rate Prostate Brachytherapy (LDR-PB) for Intermediate Risk Disease: A Population Based Cohort Analysis
err2011-10-01
err0
PREAI
errCarlson, R. G.; Morris, W. J.; Keyes, M.; Spadinger, I.; McKenzie, M.; Pickles, T.; Halperin, R.; Pai, H.; Kwan, W.
errShare
errSave